Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MT-302 |
Trade Name | |
Synonyms | MT302|MT 302 |
Drug Descriptions |
MT-302 are lipid nanoparticles containing mRNA encoding a chimeric antigen receptor (CAR) targeting TROP2, which may induce tumor killing (Cancer Res 2023;83(8_Suppl):Abstract nr LB027, Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MT-302 | MT-302 | 0 | 1 |